Sydney Finegold, MD, FIDSA, Past President of IDSA, passed away on September 17 at age 97.

IDSA and HIVMA continue to urge members of Congress to ask the Centers for Medicare & Medicaid Services (CMS) to delay the implementation of the proposed E/M payment and documentation policies and to work with the medical community to develop an alternative that is more balanced and fair to both patients and providers.

The House and Senate have announced an agreement on a final fiscal year 2019 Labor, Health and Human Services and Department of Defense appropriations bill.

The fourth annual World Antimicrobial Resistance Congress will bring 150 speakers and 400 stakeholders to Washington, D.C., Oct. 25 and 26 to discuss critical challenges and opportunities to advance antibiotic and diagnostics development.

The Clinical Laboratory and Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing met in June. Amy Mathers, MD, D(ABMM), IDSA liaison for CLSI, provided the following clinically relevant updates from the meeting.

IDSA has continued to be highly engaged in the ongoing policy discussions regarding regulation for laboratory developed tests (LDTs).

Members of Congress play JeoparIDy at the Coalition for Health Funding Public Health Fair, which was held on Capitol Hill earlier this month.

On a daily basis, IDSA spokespersons interview with media organizations across the country, providing facts, perspectives and important public health information about infectious diseases to the public.